title: Proprotein convertase subtilisin/Kexin type 9 (PCSK9) single domain antibodies are potent inhibitors of low density lipoprotein receptor degradation.
authors.forename: Elodie
authors.initials: E
authors.lastname: Weider
authors.forename: Delia
authors.initials: D
authors.lastname: Susan-Resiga
authors.forename: Rachid
authors.initials: R
authors.lastname: Essalmani
authors.forename: Josée
authors.initials: J
authors.lastname: Hamelin
authors.forename: Marie-Claude
authors.initials: MC
authors.lastname: Asselin
authors.forename: Surendra
authors.initials: S
authors.lastname: Nimesh
authors.forename: Yahya
authors.initials: Y
authors.lastname: Ashraf
authors.forename: Keith L
authors.initials: KL
authors.lastname: Wycoff
authors.forename: Jianbing
authors.initials: J
authors.lastname: Zhang
authors.forename: Annik
authors.initials: A
authors.lastname: Prat
authors.forename: Nabil G
authors.initials: NG
authors.lastname: Seidah